The Journal of Medical Sciences

Register      Login

VOLUME 11 , ISSUE 1--4 ( January-December, 2025 ) > List of Articles

RESEARCH ARTICLE

Clinical Study on Pulmonary Artery Hypertension in Patients with Cirrhosis of Liver and Its Relation with Child's Grading

NH Rekha, JashwanthGowda S, Tushar Kanth Chaudhary

Keywords : Chronic liver disease, Hepatopulmonary syndrome, Pulmonary hypertension

DOI: 10.5005/jp-journals-10045-00321

License: CC BY-NC 4.0

Published Online: 15-01-2025

Copyright Statement:  Copyright © 2025; The Author(s).


Abstract

Introduction: Cirrhosis is a diffuse fibrosis and nodular regeneration of the liver due to varied etiology, having a spectrum of clinical manifestations. There is a distinctive trail of connection between the portal system and the lung, which becomes the foremost explanation for the development of pulmonary complications in cirrhotic patients. These changes tend to occur following injury to the vascular endothelium and subsequent development of a dreaded complication, pulmonary artery hypertension (PAH), among these patients. The presence of PAH in patients with cirrhosis of the liver is known as portopulmonary hypertension (POPH), which comprises 5–10% of patients with PAH. The diagnosis of POPH has been under-recognized. This study has been carried out to evaluate the frequency of PAH in patients with cirrhosis with portal hypertension and its relation to the severity of liver disease. Objectives: (1) To measure the frequency of PAH in patients with cirrhosis of the liver. (2) To establish a relation between PAH and the severity of cirrhosis of the liver using Child–Pugh grading (A, B, C). Materials and methods: A cross-sectional study involving 100 patients, nonsmokers, diagnosed with cirrhosis of the liver between the age-group of 18–60 years, was subjected to history and examination. Investigations conducted were routine blood tests, ultrasound abdomen, Doppler study, and echocardiographic evaluation to assess Pulmonary Artery Pressure check for right atrium and right ventricular (RV) dilatation, evaluate RV systolic function, and assess inferior vena cava (IVC) collapsibility. Patients who met the inclusion criteria were assessed for the severity of liver disease using Child–Pugh grading based on clinical and laboratory criteria as A, B, and C. The severity of PAH was correlated with each grade of liver disease. Results: The mean age of patients was 49 years, with a predominant male population. Out of 100 patients, 23% had PAH of varying severity (3 trivial, 12 mild, 7 moderate, 2 severe). In our study, out of 23 patients with PAH, 3 patients with trivial PAH (25–34 mm Hg) included 1 in grade B and 2 in grade C. Among 12 patients with mild PAH (35–44 mm Hg), 7 were in grade B and 5 were in grade C. Out of 6 patients with moderate PAH (45–59 mm Hg), all 6 were in grade C. The 2 patients with severe PAH (>60 mm Hg) were both in Child's grade C. We found that PASP was significantly correlated with Child's grading (p-value 0.001). The results were statistically significant and showed a positive correlation with Child's grade. Conclusion: Pulmonary manifestations of cirrhosis carry a poor prognosis. A high index of suspicion in patients with refractory ascites, presenting with dyspnea and fatigue, can indicate decompensated disease. Bedside echocardiography is an accessible tool in the evaluation of PAH and related complications of PAH.


PDF Share
  1. Melato M, Mucli E. Something new in liver cirrhosis epidemiology. Lancet 1989;2:395–396. DOI: 10.1016/s0140-6736(89)90578-3
  2. Naveau S, Perlemuter G, Balian A. Epidemiology and natural history of cirrhosis. Rev Prat 2005;55:1527–1532. PMID: 16255293.
  3. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825–832. DOI: 10.1016/s0140-6736(96)07642-8
  4. Bellentani S, Pozzato G, Saccoccio G, et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 1999;44:874–880. DOI: 10.1136/gut.44.6.874
  5. Ganem D, Prince AM. Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med 2004;350:1118–1129. DOI: 10.1056/NEJMra031087
  6. Krowka MJ. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology 1997;25:1282–1284. DOI: 10.1002/hep.510250540
  7. Golbin JM, Krowka MJ. Portopulmonary hypertension. Clin Chest Med 2007;28:203–218. DOI: 10.1016/j.ccm.2006.11.004
  8. Saleemi S. Portopulmonary hypertension. Ann Thorac Med 2010;5(1):5–9. DOI: 10.4103/1817-1737.58953
  9. Castro M, Krowka MJ, Schroeder DR, et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc 1996;71:543–551. DOI: 10.4065/71.6543
  10. Hoffbauer FW, Rydell R. Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis. Am J Med 1956;21:450–460. DOI: 10.1016/0002-9343(56)90043-2
  11. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006;43:S121–S131. DOI: 10.1002/hep.20993
  12. Balde J, Rao NK, Ballala K, et al. Echocardiographic abnormalities in cirrhosis & their correlation with severity of cirrhosis using Child-Pugh score among patients in a tertiary care hospital. Indian J Med Res 2016;144:935–937. DOI: 10.4103/ijmr.IJMR_1486_15
  13. Naeye RL. Primary pulmonary hypertension with coexisting portal hypertension. A retrospective study of six cases. Circulation 1960;22:376–384. DOI: 10.1161/01.cir.22.3.376
  14. Kawata T, Daimon M, Nakanishi K, et al. Factors influencing inferior vena cava diameter and its respiratory variation: simultaneous comparison with hemodynamic data. J Cardiol 2022;79:642–647. DOI: 10.1016/j.jjcc.2021.11.022
  15. Benjaminov FS, Prentice M, Sniderman KW, et al. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 2003;52:1355–1362. DOI: 10.1136/gut.52.9.1355
  16. Chen HS, Xing SR, Xu WG, et al. Portopulmonary hypertension in cirrhotic patients: prevalence, clinical features and risk factors. Exp Ther Med 2013;5(3):819–824. DOI: 10.3892/etm.2013.918
  17. Gurghean AV, Tudor IA. Pulmonary hypertension in patients with hepatic cirrhosis and portal hypertension. An echographic study. Clujul Med 2017;90:161–165. DOI: 10.15386/cjmed-705
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.